TRUSOPT

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug TRUSOPT contains one active pharmaceutical ingredient (API):

1 Dorzolamide UNII QZO5366EW7 - DORZOLAMIDE HYDROCHLORIDE

Dorzolamide is a potent inhibitor of human carbonic anhydrase II. Following topical ocular administration, dorzolamide reduces elevated intra-ocular pressure, whether or not associated with glaucoma. Read about Dorzolamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRUSOPT Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EC03	Dorzolamide	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5541P, 8488R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525502401173413, 556717100001417
Country: CA	Health Products and Food Branch	Identifier(s): 02216205, 02269090
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00064997, 00990617, 00990623, 01087144, 01087150, 01607951, 01607968, 01607980, 01813969, 01813975, 01813981, 02199744, 02531598, 03245297, 03245328, 03245334, 03781541, 03781558, 03781564, 06437867, 06437873, 06437904, 07186290, 07186309, 09073704, 09073710, 11103507, 11103513, 16806969, 17264364, 17264370, 17448348
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 21.469-1-07-04
Country: EE	Ravimiamet	Identifier(s): 1014961
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60651
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 115642
Country: FR	Base de données publique des médicaments	Identifier(s): 69918085
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 102713, 13847, 140145, 374160
Country: HK	Department of Health Drug Office	Identifier(s): 40713
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-471662399
Country: IE	Health Products Regulatory Authority	Identifier(s): 57503, 57555, 57580
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3562
Country: IT	Agenzia del Farmaco	Identifier(s): 031848056
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319738Q1024, 1319738Q2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002224, 1074624
Country: MT	Medicines Authority	Identifier(s): AA1068/00501, AA1068/00502, AA565/29202
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 522M95
Country: NL	Z-Index G-Standaard	Identifier(s): 13906550
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 41556, 81027
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7153
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100068271
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62676001, W62676002
Country: SG	Health Sciences Authority	Identifier(s): 08880P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/15.4/0766